01—Abstract
Summary
Summary of the 10-Q filed October 31, 2023. Cited figures are marked; the original filing is the authoritative source.
Leidos Holdings, Inc. reported a net loss in the third quarter of fiscal 2023 (ended September 29, 2023) driven by a non-cash goodwill impairment charge of $599 milliona and an intangible asset impairment charge of $79 million, both tied to its Security Enterprise Solutions (SES) reporting unit within the Civil segment.
Revenues grew to $3.92 billionb in the quarter from $3.61 billion a year earlier, and operating results swung to a loss of $336 million from income of $281 million. For the nine months, revenues were $11.46 billion and net loss was $22 million, compared with net income of $513 million in the prior-year period. The filing states that the impairment followed reduced forecasts for SES, which was hurt by delays in airline travel infrastructure projects, and that SES's remaining goodwill is $303 million, with possible further impairments if forecasts worsen.
Segment results show Defense Solutions and Health growing, with Defense Solutions quarterly revenue of $2.22 billionc and Health revenue of $776 million, while Civil operating results were negative due to the impairments. Total backlog stood at $38.04 billion and net bookings were $7.9 billion in the quarter and $13.8 billion for the nine months.
Debt totaled roughly $4.7 billiond, cash and equivalents were $750 million, and the company refinanced its term loans in March 2023 under a new $1.0 billion term loan and $1.0 billion revolving facility maturing in March 2028. The filing also discloses ongoing uncertainty around the VirnetX/Apple patent matter, a self-reported FCPA-related internal investigation, and a DOJ Antitrust Division grand jury subpoena.
02—Key points
Key Highlights
- Net loss of $396 million in Q3 2023 versus net income of $164 million a year earlier, driven by a $599 million goodwill impairment and $79 million of intangible asset impairments in the SES unit.
- Revenues rose to $3.92 billion in Q3 from $3.61 billion, and to $11.46 billion for the nine months from $10.70 billion.
- Operating loss of $336 million in Q3 compared with operating income of $281 million a year earlier; the Civil segment posted an operating loss of $607 million for the quarter.
- Defense Solutions revenue was $2.22 billion in Q3 and Health revenue was $776 million, both up year over year.
- Total backlog was $38.04 billion at September 29, 2023, up from $35.03 billion, and net bookings were $7.9 billion in Q3 and $13.8 billion year to date.
- Cash and cash equivalents were $750 million and total debt was about $4.7 billion; the company refinanced in March 2023 with a $1.0 billion term loan and $1.0 billion revolver maturing in March 2028.
- Ongoing legal matters include the VirnetX/Apple patent case (with no assurance of proceeds), an internal FCPA-related investigation self-reported to DOJ and SEC, and a DOJ Antitrust Division grand jury subpoena.
03—One dollar
Follow one dollar
For each $1.00 of revenue in Q3 FY2024, Leidos Holdings lost $0.10.
- Revenue$3.90B100.0%
- Cost of revenue−$3.33B85.6%
- Gross profit$563.0M14.4%
- Operating costs−$899.0M23.1%
- Operating income−$336.0M8.6%
- Interest, other & tax−$63.0M1.6%
- Net income−$399.0M10.2%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2024filed October 31, 2023Financial Statements
Q3 FY2024 against Q3 FY2023
| Line item | Q3 FY2024Q3 FY2023 | Change |
|---|---|---|
| Revenue | $3.90B$3.58B | +8.9% |
| Cost of Revenue | $3.33B$3.10B | +7.7% |
| Gross Profit | $563.00M$484.00M | +16.3% |
| SG&A Expenses | $239.00M$232.00M | +3.0% |
| Operating Income | -$336.00M$281.00M | −219.6% |
| Net Income | -$399.00M$162.00M | −346.3% |
| EPS (Basic) | $-2.91$1.18 | −346.6% |
| EPS (Diluted) | $-2.91$1.17 | −348.7% |
| Shares Outstanding (Basic) | 137.00M137.00M | 0.0% |
| Shares Outstanding (Diluted) | 137.00M138.00M | −0.7% |
05—Questions
Frequently Asked Questions
Why did Leidos report a net loss this quarter?
The loss was driven mainly by a non-cash goodwill impairment charge of $599 million and intangible asset impairment charges of $79 million, both related to the Security Enterprise Solutions (SES) reporting unit. The filing says SES was hurt by delays in airline travel infrastructure projects and higher-than-anticipated servicing costs, which reduced its forecasted revenue and cash flows.
How did the company's segments perform?
Defense Solutions revenue rose to $2.22 billion in the third quarter from $2.08 billion, with operating income of $147 million. Health revenue rose to $776 million from $659 million, with operating income of $152 million. Civil revenue was $924 million, but it posted an operating loss of $607 million, reflecting the impairment charges.
What is the company's debt and liquidity position?
At September 29, 2023, the company had $750 million in cash and cash equivalents and outstanding debt of $4.7 billion. It had no borrowings under its $1.0 billion revolving facility and no commercial paper outstanding. The company said it was in compliance with all covenants and expects to meet liquidity needs for the next 12 months through operations, cash balances, commercial paper and, if needed, its revolver.
Could there be further goodwill impairments?
The filing states that SES goodwill remaining after the impairment is $303 million, and that if forecasted cash flows, revenue, terminal growth rates or the cost of capital change unfavorably, the company may be required to record additional goodwill or intangible asset impairments in the future.
What are the main legal and regulatory risks disclosed?
The filing discloses an internal investigation into international operations, self-reported to the DOJ and SEC, that may involve violations of the U.S. Foreign Corrupt Practices Act, and a DOJ Antitrust Division grand jury subpoena related to three U.S. government procurements. It also notes that proceeds from the VirnetX/Apple patent case remain uncertain, with no assurance of receipt.
06—Continue